Technology has been aiding the growth of cannabis for a long time, but with attitudes to its medical use around the world changing, it now offers more potential than ever before.
It’s possible that the drug could create a new breed of medical cannabis entrepreneurs who look to sell it for medical uses in a variety of ways.
One of these has already started an app to allow patients to be consulted for treatment with marijuana.
In the US, legal sales of the drug are predicted to top $2.3bn this year – up more than a billion dollars compared to 2013.
This will be greatly aided by the US House of Representatives voting to allow individual states in the country to rule on medical cannabis use on their own.
Barack Obama also said in an interview that he believes cannabis is no more dangerous than alcohol.
A glimpse into the rapid growth of medical cannabis can clearly be seen from the ambitious number of projects that are looking to secure their futures on crowdfunding websites.
One of these is trying to raise $100,000 to fund a marijuana doctor service that gives consultations and recommendations without you ever having to leave you home – via a smartphone, tablet or even on the web.
The connection, from AbacaRx, is also encrypted.
It’s campaign page explains: “Due to the stigma attached to medical marijuana, people often feel uncomfortable talking to their family doctor, and therefore, don’t get the medical consultation they seek.”
It allows users of the drug, for medical purposes, to get consultations on their usage. It involves a 15 minute doctor consultation with board-certified doctors, who provide an assessment and decide if you should be recommended medical marijuana.
One company that is benefitting from the drug’s popularity as a medical tool is Cannabis Science.
It says the financial environment has grown massively since 2009 when it was founded and that legal and social developments have also been favourable.
Earlier this year it successfully raised capital which shows the potential scope for the drug to be used in a medical sense.
Robert Kane, CFO of Cannabis Science said: “Cannabis Science is in the strongest financial position in the Company’s history.
“With a positive cash position after the successful capital raise earlier this year, the Company has the ability to conduct basic science research and to begin new cannabis-drug development programs.
In fact, this has begun and our development team is analyzing proprietary data right now.”
Image two courtesy of Abacarx